Rare diseases
Investigational molecules
Locations
Study on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis
SpainStudy of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
SpainStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration
SpainStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
SpainStudy on Long-Term Safety of INBRX-101 for Adults with Alpha-1 Antitrypsin Deficiency Emphysema
SpainStudy on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
SpainStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
SpainStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
SpainStudy on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia
SpainStudy of Efgartigimod for Adults with Thyroid Eye Disease
SpainStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
